(R)-1-氨基-3-甲基丁基硼酸蒎烷二醇酯三氟乙酸盐
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate;(R)-BoroLeu-(+)-Pinanediol trifluoroacetate;(1R)-(S)-Pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate;(1R)-(S)-PINANEDIOL-1-AMINO-3-METHYLBUTANE-1-BORONATE, TRIFLUOROACETATE;(R)-BoroLeu-(+)-Pinanediol-CF3COOH;(R)-BoroLeu-(+)-pinanediol-trifluoroacetate;(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate;(αR)-(1S,2S,3R,5S)-P;(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate;(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt;(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate;Bortezomib INT A;Ixazomib intermediate;Bortezomib Intermediates;Bortezomib Intermediate 1;Bortezomib Intermediate A;Pinanedioltrifluoroacetate salt-;(R)-BoroLeu-(+)-Pinanediol-CF3CO2H;(R)-BoroLeu-(+)-Pinanediol-CF3COOH N-4;(R)-3-METHYL-1-((3AS,4S,6S,7AR)-3A,5,5-TRIMETHYLHEXAHYDRO-4,6-METHANOBENZO[D][1,3,2]DIOXABOROL-2-YL)BUTAN-1-AMINE 2,2,2-TRIFLUOROACETATE;(1R)-(S)-Pinanediol 1-ammoni;(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02?]decan-4-yl]butan-1-amine;2,2,2-trifluoroacetic acid;(R)-BoroLeu-(+)-Pinanedioltrifluoroacetate;AC-2355;(1R)-3-METHYL-1-[(1S,2S,6R,8S)-2,9,9-TRIMETHYL-3,5-DIOXA-4-BORATRICYCLO[6.1.1.0(2),?]DECAN-4-YL]BUTAN-1-AMINE; TRIFLUOROACETIC ACID;Z3082065227;(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluor oacetate;(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0^{2,6}]decan-4-yl]butan-1-amine; trifluoroacetic acid;MFCD10566030;(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt;AKOS015896703;Trifluoroacetic acid--(1R)-3-methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-2H-4,6-methano-1,3,2-benzodioxaborol-2-yl]butan-1-amine (1/1);(?R)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt;EN300-7390232;Q-102518;(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]butan-1-amine;2,2,2-trifluoroacetic acid;(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0?,?]decan-4-yl]butan-1-amine; trifluoroacetic acid;BS-2025;A846442;DTXSID00658025;(R)-BOROLEU-(+)-PINANEDIOL TFA;CS-W019140;(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0,2,6]decan-4-yl]butan-1-amine; trifluoroacetic acid;4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-, (alphaR,3aS,4S,6S,7aR)-, 2,2,2-trifluoroacetate (1:1);AMY4256;(aR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trif...